Cell Bio Human Tech

셀바이오휴먼텍 · 318160

Consumer Discretionary Consumer Durables · KOSDAQ

Small-cap

Market cap US$37.4M (₩51.6B)

Overview

Cell Bio Human Tech makes the fabric sheet material used inside face mask packs, the thin, skin-adhering layer that holds skincare serum against the face.

It supplies this cellulose-based material to cosmetics manufacturers, and also produces hydrocolloid patch products used in cosmetic applications. Listed on KOSDAQ, Korea's tech and small-cap board, the company has expanded beyond its core mask-pack material into contract manufacturing of finished cosmetic products, including sheet masks, pads, and hydrogel mask packs.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$37M

▲ +79.7% YoY

Operating profit · FY2025

US$6.8M

▲ +130.8% YoY

Net income · FY2025

US$6.3M

▲ +98.6% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$19.8M(₩27.3B)	US$20.6M(₩28.4B)	US$37M(₩51.1B)
Operating profit	US$2.3M(₩3.1B)	US$2.9M(₩4B)	US$6.8M(₩9.3B)
Net income	−US$1.3M(−₩1.9B)	US$3.2M(₩4.4B)	US$6.3M(₩8.7B)

Revenue

FY2023US$19.8M
FY2024US$20.6M
FY2025US$37M

Operating profit

FY2023US$2.3M
FY2024US$2.9M
FY2025US$6.8M

Net income

FY2023−US$1.3M
FY2024US$3.2M
FY2025US$6.3M

Key ratios (FY2025)

ROE

14.7%

Debt/Eq

49.9%

Op. margin

18.3%

Net margin

17.0%

Rev. YoY

▲ +79.7%

Why it matters

The company was founded by a researcher from the Korea Institute of Industrial Technology, applying medical textile research to develop a domestically produced alternative to imported mask-pack materials.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?